目的 通过比较新疆维吾尔族妇女宫颈癌组织与正常宫颈中NF-κB表达水平的差异,了解新疆维吾尔族妇女宫颈癌组织与NF-κB的关系及意义。方法 采用含 20 000 条 Oligo DNA 的人类全基因组寡核苷酸芯片,对5 例新疆维吾尔族妇女宫颈癌组织与5 例正常宫颈成组检测差异表达基因,通过 MAS 分析得到两组间差异表达基因NF-κB。采用实时荧光定量PCR及免疫组化对62例宫颈癌,17例正常宫颈组织中NF-κB进行检测,并分析各分子表达水平与相应临床病理指标的关系。结果 62例宫颈癌组织NF-κB mRNA的相对表达量为(0.668±0.045),17例正常宫颈NF-κB mRNA的相对表达量为(0.473±0.032),宫颈癌组织中NF-κBmRNA的相对表达量均显著高于正常宫颈组,差异有统计学意义。免疫组织化学SP法结果显示(1)NF-κB蛋白在宫颈癌组和正常宫颈组中阳性表达率分别为51.61% 和11.76%。釆用组间卡方检验,差异有统计学意义。(2)宫颈癌组织中NF-kB蛋白阳性表达与临床和病理资料相关性分析结果显示,年龄≥65岁患者NF-kB蛋白阳性表达率为72.73%,年龄<65岁患者 NF-κB蛋白阳性表达率为51.72%,卡方检验显示差异无统计学意义;NF-κB蛋白在宫颈癌低分化组、中分化组的表达水平明显均高于高分化组,差异有统计学意义; NF-κB蛋白在宫颈癌III期,IV期的表达水平均显著高于I+II期,差异有统计学意义。结论 NF-κBmRNA和蛋白在宫颈癌中存在高表达,NF-kB蛋白的阳性表达随着宫颈癌的分化程度和临床分期的升高逐步升高。
关键词
宫颈肿瘤 /
全基因组寡核苷酸芯片 /
实时荧光定量PCR /
免疫组化 /
NF-κB
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
1 Parkin DM,Bray F,Ferlay J,et al.Estimatingtheworldcancerbur-den:GLOBOCAN2000.IntCancer,2001,94:153-156.
2 Courtois G,GilmoreTD.Mutations in the NF-kappaB signaling pathway:implications for human disease.Oncogene,2006,25:6831-6843.
3 Gilmore TD.NF-kappa B,KBF1,dorsal,and related matters.Cell,1990,62:841-843.
4 Gilmore TD.Introduction to NF-kappaB:players,pathways,perspectives.Oncogene,2006,25:6680-6684.
5 Sclabas GM,Uwagawa T,Schmidt C,et al.Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin.Cancer,2005,103:2485-2490.
6 Kalaitzidis D,Gilmore TD.Transcription factor crosstalk;the estrogen receptor and NF-kappaB.Trends Endocrinol Metab,2005,16:46-52.
7 Karin M,Cao Y,Greten FR,et al .NF- kB in cancer:from innocent by slander to major culprit.Nat Rev Cmcer,2002,2:301-310.
8 Beg AA,Baltimore D.An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.Science,1996,274:782-784.
9 Rodríguez-Berriguete G,Fraile B,Paniagua R,et al.Expression of NF-kB-related proteins and their modulation during TNF-a-provoked apoptosis in prostate cancer celIs. Prostate,2012,72:40-50.
10 Mimeault M,Johansson SL,Batra SK.Pathobiological implications of the expression of EGFR,pAkt,NF-KB and MIC-1 in prostate cancer stem cells and their progenies.PLoS One,2012,7:e31919.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
新疆医科大学科研创新基金项目(XYDCX2014)
{{custom_fund}}